Unlock stock picks and a broker-level newsfeed that powers Wall Street.
16.35
+1.58
+(10.70%)
At close: 4:00:01 PM EDT
16.35
0.00
(0.00%)
After hours: 4:06:20 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 9 | 8 |
| Avg. Estimate | -0.69 | -0.72 | -2.81 | -2.48 |
| Low Estimate | -0.86 | -0.92 | -3.64 | -3.48 |
| High Estimate | -0.59 | -0.58 | -2.35 | -1.87 |
| Year Ago EPS | -0.53 | -0.68 | -3.36 | -2.81 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 10 | 10 | 12 | 12 |
| Avg. Estimate | 2.1M | 2.4M | 16.22M | 56.9M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | 6.16M | 8M | 43.2M | 174.47M |
| Year Ago Sales | -- | -- | 7M | 16.22M |
| Sales Growth (year/est) | 0.00% | 0.00% | 131.71% | 250.81% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.5 | -0.53 | -0.6 | -0.62 |
| EPS Actual | -0.53 | -0.68 | -0.6 | -1.49 |
| Difference | -0.03 | -0.15 | 0 | -0.87 |
| Surprise % | -5.45% | -28.84% | 0.76% | -139.37% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.69 | -0.72 | -2.81 | -2.48 |
| 7 Days Ago | -0.71 | -0.74 | -2.89 | -2.71 |
| 30 Days Ago | -0.71 | -0.74 | -2.89 | -2.71 |
| 60 Days Ago | -0.64 | -0.69 | -2.71 | -2.56 |
| 90 Days Ago | -0.64 | -0.67 | -2.71 | -2.56 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | 1 |
| Up Last 30 Days | 1 | 2 | 4 | 3 |
| Down Last 7 Days | 1 | 1 | 1 | 3 |
| Down Last 30 Days | 1 | -- | 4 | 4 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| IDYA | -30.27% | -5.15% | 16.37% | 11.61% |
| S&P 500 | 6.69% | 6.80% | 9.98% | 14.34% |
Upgrades & Downgrades
| Reiterates | Stephens & Co.: Overweight to Overweight | 2/14/2025 |
| Reiterates | RBC Capital: Outperform to Outperform | 1/15/2025 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 1/13/2025 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 12/17/2024 |
| Reiterates | Wedbush: Outperform to Outperform | 12/17/2024 |
| Initiated | Stephens & Co.: Overweight | 11/18/2024 |
Related Tickers
SWTX SpringWorks Therapeutics, Inc.
46.52
+11.08%
RVMD Revolution Medicines, Inc.
34.60
+2.91%
VRDN Viridian Therapeutics, Inc.
13.07
+4.06%
KYMR Kymera Therapeutics, Inc.
26.36
+4.46%
CGEM Cullinan Therapeutics, Inc.
7.82
+4.27%
CRNX Crinetics Pharmaceuticals, Inc.
31.39
+2.51%
RCUS Arcus Biosciences, Inc.
7.89
+2.33%
STOK Stoke Therapeutics, Inc.
6.60
+5.94%
PTGX Protagonist Therapeutics, Inc.
48.20
+2.82%
CYTK Cytokinetics, Incorporated
40.25
+7.33%